Shell com­pa­ny Con­cen­tra has found its rhythm, with Car­go Ther­a­peu­tics as its lat­est buy­out tar­get

Kevin Tang’s Con­cen­tra Bio­sciences has inked its fifth buy­out of the sea­son, this time forg­ing a deal to take out cell ther­a­py biotech Car­go Ther­a­peu­tics …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.